Good Day BIO: PBM rebates don’t reach patients, analysis finds

August 11, 2022
A new analysis of Texas data shows—surprise, surprise—PBMs don’t pass on rebates and savings from drug makers to patients. Plus, we look at how biotech is resurrecting what’s considered Latin America’s oldest beer. Meanwhile, we’re keeping an eye on the House, which…
Biotechnology Innovation Organization (BIO)
 
 
 
 
BIO Beltway Report
Facebook
Twitter
LinkedIn
YouTube